Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
PAVmed Inc
PAVMCurrent price
0.66 USD
+0.069 USD (+11.62%)
Last closed
0.61 USD
Company
www.pavmed.com
ISIN
US70387R1068
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Capitalization
7 973 819 USD
Yield for 12 month
-65.45 %
1Y
3Y
5Y
10Y
15Y
PAVM
PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York. Address: 360 Madison Avenue, New York, NY, United States, 10017
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
9.00 USDP/E ratio
–Dividend Yield
–Current Year
+2 452 000 USD
Last Year
+377 000 USD
Current Quarter
+996 000 USD
Last Quarter
+979 000 USD
Current Year
-3 968 000 USD
Last Year
-3 237 000 USD
Current Quarter
-385 000 USD
Last Quarter
-992 000 USD
Key Figures PAVM
1 year
3 years
5 years
10 years
EBITDA
-57 284 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-80.07 %
PEG Ratio
–
Return On Equity TTM
-1 358.06 %
Wall Street Target Price
9.00 USD
Revenue TTM
3 829 000 USD
Book Value
-6.62 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
489.80 %
Dividend Yield
–
Gross Profit TTM
-3 237 000 USD
Earnings per share
-1.14 USD
Diluted Eps TTM
-1.14 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics PAVM
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History PAVM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:15
Payout Ratio
–
Last Split Date
07.12.2023
Stock Valuation PAVM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
11.25
Price Sales TTM
2.08
Enterprise Value EBITDA
3.85
Price Book MRQ
7.42
Financials PAVM
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators PAVM
For 52 weeks
0.60 USD
4.44 USD
50 Day MA
1.04 USD
Shares Short Prior Month
269 905
200 Day MA
1.37 USD
Short Ratio
9.07
Shares Short
286 534
Short Percent
3.09 %
BeatStart